English | Español
Gene Johnson | Mar 9, 2017

Sigma-Tau Pharmaceuticals changes name to Leadiant Biosciences
Gene Johnson | Mar 9, 2017

Ferring, Foresee Pharmaceuticals enter exclusive development deal
Robert Lawson | Mar 9, 2017

AMA writes amicus brief to support proper medical testimony
Gene Johnson | Mar 9, 2017

FDA approves Qtern for treatment of Type 2 diabetes
Gene Johnson | Mar 9, 2017

Aurinia Pharmaceuticals CEO speaks at health care conference
Gene Johnson | Mar 9, 2017

Registration open for National Psoriasis Foundation's biennial conference

Gene Johnson | Mar 9, 2017

Survey shows diabetics unaware of increased risk for serious illnesses
Erianne Leatherman | Mar 8, 2017

Study reveals adolescents with Type 2 diabetes more susceptible to complications

Trending
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Pharmaceuticals
Patient Daily | May 8, 2025

National Library of Medicine says compounded drugs like GLP-1 offer tailored alternatives to FDA-approved treatments